New IPO guide for life sciences companies to launch


AusBiotech is pleased to invite you to the Melbourne or Sydney launch events of the recently-completed 'Roadmap to a successful IPO for life sciences companies'.

Complimentary registrations are now open to join AusBiotech CEO, Glenn Cross, and guest speakers, including ASX Chairman, Rick Holliday-Smith (Sydney) and ASX Manager Listings, James Gerraty (Melbourne), at networking events to celebrate the launch of the Roadmap.

AusBiotech, in partnership with Australian Securities Exchange (ASX), KPMG, DibbsBarker and WE Buchan, has developed the Roadmap aimed at preparing life sciences companies for an initial public offering (IPO). The Roadmap is one of the three main components of the MTPConnect-funded ‘Comprehensive Global Investment Program for the Australian Life Sciences Sector – companies, investors and researchers’ project.

The Roadmap is predominantly aimed at life sciences companies that are investor-ready or planning to become investor-ready. Listing on ASX is a common pathway for life sciences companies. The Roadmap, and the implementation of complementary workshops, will provide companies with independent expert information specific to the life sciences sector about listing on ASX.

ASX Sydney

Exchange Square, 18 Bridge St

Wednesday 20 September 2017

5.30 – 7.00pm

KPMG Melbourne

Collins Square, 727 Collins St

Tuesday 3 October 2017

5.30 – 7.00pm 

Free registration